Impact of routine bedside infectious disease consultation on clinical management and outcome of Staphylococcus aureus bacteraemia in adults

Clinical Microbiology and Infection

Volumn 21, Issue 8, 2015, Pages 779-785

  Saunderson, R B ^a   Gouliouris, T ^b,c,d   Nickerson, E K ^d   Cartwright, E J P ^b   Kidney, A ^b   Aliyu, S H ^c,d   Brown, N M ^c   Limmathurotsakul, D ^e   Peacock, S J ^b,c,e   Torok M E ^b,c,d  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Bacteraemia; Infectious disease consultation; Outcome; Staphylococcus aureus; Treatment

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; CENTRAL VENOUS CATHETER; CLINICAL FEATURE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEART VALVE PROSTHESIS; HOSPITAL DISCHARGE; HUMAN; JOINT PROSTHESIS; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PERIPHERAL VENOUS CATHETER; POINT OF CARE TESTING; PRIORITY JOURNAL; STAPHYLOCOCCAL BACTEREMIA; TEACHING HOSPITAL; TELECONSULTATION; UNITED KINGDOM; VASCULAR IMPLANT; BACTEREMIA; COHORT ANALYSIS; ISOLATION AND PURIFICATION; PATIENT REFERRAL; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

STAPHYLOCOCCUS AUREUS;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; COHORT STUDIES; FEMALE; HOSPITALS, TEACHING; HUMANS; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED KINGDOM; YOUNG ADULT;

EID: 84937524206     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.05.026     Document Type: Article

References (30)

1. Hill P.C., Birch M., Chambers S., et al. Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J 2001, 31:97-103.
2. Mylotte J.M., Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 2000, 31:1170-1174.
3. Rieg S., Peyerl-Hoffmann G., de With K., et al. Mortality of S. aureus bacteremia and infectious diseases specialist consultation-a study of 521 patients in Germany. J Infect 2009, 59:232-239.
4. Gros H., Aslangul E., Lesprit P., Mainardi J.L. Positive blood culture in hospital: notification methods and impact of recommendations by an infectious disease specialist. Med Mal Infect 2012, 42:76-79. Ile-de-France Infectious Diseases Experts Group.
5. Byl B., Clevenbergh P., Jacobs F., et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 1999, 29:60-66.
6. Kerremans J.J., Verbrugh H.A., Vos M.C. Frequency of microbiologically correct antibiotic therapy increased by infectious disease consultations and microbiological results. J Clin Microbiol 2012, 50:2066-2068.
7. Cunney R.J., McNamara E.B., Alansari N., Loo B., Smyth E.G. The impact of blood culture reporting and clinical liaison on the empiric treatment of bacteraemia. J Clin Pathol 1997, 50:1010-1012.
8. Fowler V.G., Sanders L.L., Sexton D.J., et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998, 27:478-486.
9. Jenkins T.C., Price C.S., Sabel A.L., Mehler P.S., Burman W.J. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis 2008, 46:1000-1008.
10. Nagao M., Iinuma Y., Saito T., et al. Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect 2010, 16:1783-1788.
11. Robinson J.O., Pozzi-Langhi S., Phillips M., et al. Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia. Eur J Clin Microbiol Infect Dis 2012, 31:2421-2428.
12. Tissot F., Calandra T., Prod'hom G., et al. Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality. J Infect 2014, 69:226-234.
13. Lundberg J., Nettleman M.D., Costigan M., Bentler S., Dawson J., Wenzel R.P. Staphylococcus aureus bacteremia: the cost-effectiveness of long-term therapy associated with infectious diseases consultation. Clin Perform Qual Health Care 1998, 6:9-11.
14. Lillie P., Moss P., Thaker H., et al. Development, impact and outcomes of the Hull Bacteraemia Service. QJM 2008, 101:889-898.
15. Forsblom E., Ruotsalainen E., Ollgren J., Jarvinen A. Telephone consultation cannot replace bedside infectious disease consultation in the management of Staphylococcus aureus bacteremia. Clin Infect Dis 2013, 56:527-535.
16. Holland T.L., Arnold C., Fowler V.G. Clinical management of Staphylococcus aureus bacteremia: a review. JAMA 2014, 312:1330-1341.
17. Libman H., Arbeit R.D. Complications associated with Staphylococcus aureus bacteremia. Arch Intern Med 1984, 144:541-545.
18. Li J.S., Sexton D.J., Mick N., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633-638.
19. Friedman N.D., Kaye K.S., Stout J.E., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137:791-797.
20. Liu C., Bayer A., Cosgrove S.E., et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011, 52:285-292.
21. Gould F.K., Denning D.W., Elliott T.S., et al. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2012, 67:269-289.
22. Habib G., Hoen B., Tornos P., et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version, 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009, 30:2369-2413.
23. Osmon D.R., Berbari E.F., Berendt A.R., et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013, 56:e1-e25.
24. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
25. Lesens O., Methlin C., Hansmann Y., et al. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infect Control Hosp Epidemiol 2003, 24:890-896.
26. Mermel L.A., Allon M., Bouza E., et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 49:1-45.
27. Fowler V.G., Olsen M.K., Corey G.R., et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003, 163:2066-2072.
28. Chang F.Y., MacDonald B.B., Peacock J.E., et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 2003, 82:322-332.
29. Calain P., Krause K.H., Vaudaux P., et al. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. J Infect Dis 1987, 155:187-191.
30. Fortun J., Navas E., Martinez-Beltran J., et al. Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin. Clin Infect Dis 2001, 33:120-125.